Company / Operating Income per Share
Coherus Oncology, Inc. Operating Income per Share History
FY2014-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
$1.58
FY2019
5-year range
-$5.07 / $1.58
FY2015-FY2019
Trend
+146.2%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $-5.07 to $1.58 over the past 2 years.
Based on SEC 10-K filings.
1.58 in FY2019.
Improved from $-5.07 to $1.58 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2019, operating income per share increased 146.2% year-over-year.
- Lowest operating income per share in the period was in FY2014.
Company context
Key Data Points
- Altman Z-Score -0.49 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | $1.58 | +146.2% |
| FY2018 | -$3.42 | +32.6% |
| FY2017 | -$5.07 | -205.6% |
| FY2016 | -$1.66 | -53.2% |
| FY2015 | -$1.08 | +86.4% |
| FY2014 | -$7.96 | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026